Q3 2025 Gentex Corp Earnings Call Transcript
Key Points
- Gentex Corp (GNTX) reported consolidated net sales of $655.2 million for Q3 2025, an 8% increase compared to the same period last year.
- The acquisition of Vox contributed $84.9 million in revenue, aiding overall sales growth.
- North American OEM revenue increased by approximately 5% quarter over quarter, supported by robust production schedules and increased content per vehicle.
- The company's consolidated gross margin improved to 34.4% from 33.5% in the previous year, driven by favorable North American customer and product mix, purchasing cost reductions, and operational efficiencies.
- Gentex Corp (GNTX) repurchased 1 million shares of its common stock, reflecting confidence in its financial position and future prospects.
- Core Gentex revenue declined by 6% compared to the third quarter of last year, excluding Vox.
- European revenue declined approximately 14% quarter over quarter due to customer-specific production challenges and a weaker regional vehicle mix.
- Revenue in China fell by 35% compared to the third quarter of last year, impacted by ongoing tariff and counter-tariff actions.
- Consolidated operating expenses increased to $102.8 million from $78.3 million in the previous year, primarily due to the Vox acquisition.
- Consolidated net income attributable to Gentex Corp (GNTX) decreased to $101 million from $122.5 million in the third quarter of last year, largely due to a one-time gain in the prior period.
Good day and thank you for standing by. Welcome to the Gentech 3rd quarter of 2025 financial results conference call. At this time, all participants are listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 111 on your telephone. You will then hear automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I'd like to hand the conference over to your first speaker today, Josh Opersky, director of investor relations, please go ahead.
' -
Thank you.
Good morning and thank you for joining us today for a 3rd quarter 2025 earnings conference call. I'm Jos Obersky, Gentech's director of investor relations, and with me today are Steve Downing, President and CEO, Neil Baim, COO and CTO, and Kevin Nash, Vice President of finance and CFO.
Please note that a replay of this conference
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
